b 572 (Methotrexate 2.5 mg)

Pill imprint b 572 has been identified as Methotrexate sodium 2.5 mg.

Methotrexate is used in the treatment of rheumatoid arthritis; psoriasis; psoriatic arthritis; acute lymphoblastic leukemia; small cell lung cancer (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for b 572

Methotrexate sodium 2.5 mg b 572
Methotrexate sodium 2.5 mg b 572  Front
Methotrexate sodium 2.5 mg b 572  Back
Methotrexate sodium 2.5 mg b 572
Methotrexate sodium
Imprint:
b 572
Strength:
2.5 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
IVAX Pharmaceuticals Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)